![John Hamer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Hamer
Director/Board Member at
E-Markets, Inc.
Profile
Dr. John E.
Hamer is a Managing Partner, DCVC Bio at DCVC Management Co. LLC and a Director at Golden Pine Ventures LLC.
He is on the Board of Directors at Atomwise, Inc., Nidus Investment Partners LP, BioPhero ApS, E-Markets, Inc., Solu Therapeutics, Inc., Umoja Biopharma, Inc. and Unlearn.AI, Inc.
Dr. Hamer was previously employed as an Independent Director by AbCellera Biologics, Inc., a Managing Director by Monsanto Growth Ventures, a Chairman by Chromatin, Inc., a Chief Executive Officer by Arête Therapeutics, Inc., a Managing Director by Burrill & Co. LLC, a Chief Executive Officer & Vice President by Icoria, Inc., a CSO, CEO, VP Business Development by Icoria, Inc., a Professor by Purdue University, and a Chairman by Sentinext Therapeutics Sdn.
Bhd.
He also served on the board at Malaysian Life Sciences Capital Fund Management Co. Ltd., Chlorogen, Inc., Cobalt Technologies, Inc., CropDesign NV and NanoVasc, Inc.
He received his undergraduate degree from the University of Windsor, a graduate degree from the University of Windsor and a doctorate degree from the University of California, Davis.
John Hamer active positions
| Companies | Position | Start |
|---|---|---|
E-Markets, Inc.
 E-Markets, Inc. Packaged SoftwareTechnology Services Provides e-commerce solutions and services | Director/Board Member | - |
Golden Pine Ventures LLC
 Golden Pine Ventures LLC Investment ManagersFinance Golden Pine Ventures LLC invests in companies located in the US. They target companies operating in the fields of biotechnology and biomedical opportunities which have the potential to yield a substantial return within a 3 to 5-year period. They provide financing for seed and early stage capital requirements. The firm seeks an equal equity ownership position in these new companies. | Private Equity Investor | - |
Umoja Biopharma, Inc.
 Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Director/Board Member | - |
DCVC Management Co. LLC
 DCVC Management Co. LLC Investment ManagersFinance DCVC invests in companies located in the United states and Europe. The firm target companies operating mainly in the deep technology sector. It provides financing for seed, early, and later stage capital requirements. It also participates in subsequent rounds. | Private Equity Investor | 31/03/2018 |
Atomwise, Inc.
 Atomwise, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence platform that explores the vast universe of chemical space to discover novel and drug-like molecules | Director/Board Member | 17/06/2021 |
Unlearn.AI, Inc.
 Unlearn.AI, Inc. Packaged SoftwareTechnology Services Develops an AI-powered platform that generates digital twins to simulate and optimize clinical trials in medicine | Director/Board Member | - |
Nidus Investment Partners LP
 Nidus Investment Partners LP Investment ManagersFinance Nidus Investment Partners invests in companies located in the United States. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Director/Board Member | - |
Solu Therapeutics
 Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Director/Board Member | - |
Former positions of John Hamer
| Companies | Position | End |
|---|---|---|
| ABCELLERA BIOLOGICS INC. | Director/Board Member | 06/12/2021 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Training of John Hamer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
80
1st degree connections
24
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 24 |
|---|---|
Cogenics Icoria, Inc.
 Cogenics Icoria, Inc. Miscellaneous Commercial ServicesCommercial Services Provides medical research services | Commercial Services |
Chromatin, Inc.
 Chromatin, Inc. BiotechnologyHealth Technology Provides seed and feedstock products for agriculture and bio-industrial processes | Health Technology |
Arête Therapeutics, Inc.
 Arête Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Develops and commercializes molecule drugs to treat cardiovascular diseases | Health Technology |
Cobalt Technologies, Inc.
 Cobalt Technologies, Inc. Chemicals: SpecialtyProcess Industries Develops, produces and commercializes bio-based chemicals | Process Industries |
NanoVasc, Inc.
 NanoVasc, Inc. Miscellaneous Commercial ServicesCommercial Services Provides biotechnology development and research services | Commercial Services |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burrill invests in companies located in the United States. The firm focuses on a broad range of sectors. It participates in buyout and early-stage transactions. | Finance |
E-Markets, Inc.
E-Markets, Inc. Packaged SoftwareTechnology Services Provides e-commerce solutions and services | Technology Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Windsor
 University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CropDesign NV
 CropDesign NV Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops traits for cereal crops | Commercial Services |
Chlorogen, Inc.
 Chlorogen, Inc. Pharmaceuticals: MajorHealth Technology Develops plant-made drugs and vaccines | Health Technology |
Malaysian Life Sciences Capital Fund Management Co. Ltd.
 Malaysian Life Sciences Capital Fund Management Co. Ltd. Investment ManagersFinance MLSCFM invests in companies located in Malaysia. The firm targets companies operating in the fields of agriculture, healthcare and industrial biotechnology development sectors. It provides financing for early and later stage capital requirements. | Finance |
Golden Pine Ventures LLC
Golden Pine Ventures LLC Investment ManagersFinance Golden Pine Ventures LLC invests in companies located in the US. They target companies operating in the fields of biotechnology and biomedical opportunities which have the potential to yield a substantial return within a 3 to 5-year period. They provide financing for seed and early stage capital requirements. The firm seeks an equal equity ownership position in these new companies. | Finance |
Sentinext Therapeutics Sdn. Bhd.
 Sentinext Therapeutics Sdn. Bhd. BiotechnologyHealth Technology Develops vaccines and therapeutics for tropical infectious diseases | Health Technology |
DCVC Management Co. LLC
DCVC Management Co. LLC Investment ManagersFinance DCVC invests in companies located in the United states and Europe. The firm target companies operating mainly in the deep technology sector. It provides financing for seed, early, and later stage capital requirements. It also participates in subsequent rounds. | Finance |
Nidus Investment Partners LP
Nidus Investment Partners LP Investment ManagersFinance Nidus Investment Partners invests in companies located in the United States. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed and early stage capital requirements. | Finance |
AbCellera Biologics, Inc.
 AbCellera Biologics, Inc. BiotechnologyHealth Technology Discovers and develops antibody drugs & therapeutics | Health Technology |
Monsanto Growth Ventures
 Monsanto Growth Ventures Investment ManagersFinance MGV seeks investment opportunities in companies located in the United States. The firm targets companies operating in the fields of agricultural productivity, biologicals and digital agriculture industries. It provides financing for seed, early and growth stage capital requirements. | Finance |
Atomwise, Inc.
Atomwise, Inc. Packaged SoftwareTechnology Services Develops artificial intelligence platform that explores the vast universe of chemical space to discover novel and drug-like molecules | Technology Services |
BioPhero ApS
 BioPhero ApS Miscellaneous Commercial ServicesCommercial Services Operates as a pheromone research and production company | Commercial Services |
Unlearn.AI, Inc.
Unlearn.AI, Inc. Packaged SoftwareTechnology Services Develops an AI-powered platform that generates digital twins to simulate and optimize clinical trials in medicine | Technology Services |
Umoja Biopharma, Inc.
Umoja Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for treatment of cancer therapies | Health Technology |
Solu Therapeutics
Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Health Technology |
- Stock Market
- Insiders
- John Hamer
